How to Conduct a Technical File Gap Assessment for Overseas Medical Device Registration

Published: July 9, 2026, 09:00 | Updated: July 9, 2026, 09:00

A technical file gap assessment for overseas medical device registration should be completed before formal submission. The core task is to compare the company's existing documentation against the regulatory requirements of the target country item by item, to determine whether classification, performance testing, clinical evidence, risk management, software cybersecurity, labeling and instructions for use, quality system, and post-market surveillance materials are sufficient to support the application. It is not a simple check of whether documents exist, but an assessment of whether the evidence chain is complete, whether documents are consistent with each other, and whether product claims are supported by data. The results of the gap assessment directly affect project timelines, budgets, additional testing needs, translation workload, and deficiency response risks.

Key Summary

A technical file gap assessment for overseas medical device registration should be completed before formal submission. The core task is to compare the company's existing documentation against the regulatory requirements of the target country item by item, to determine whether classification, performance testing, clinical evidence, risk management, software cybersecurity, labeling and instructions for use, quality system, and post-market surveillance materials are sufficient to support the application. It is not a simple check of whether documents exist, but an assessment of whether the evidence chain is complete, whether documents are consistent with each other, and whether product claims are supported by data. The results of the gap assessment directly affect project timelines, budgets, additional testing needs, translation workload, and deficiency response risks.

Who Should Read This

Companies that already have domestic registration documentation, CE documentation, or historical export experience, but are uncertain whether these can be used directly for target country submissions, should first conduct a technical file gap assessment. It is particularly suitable for multi-country registrations, complex active devices, in vitro diagnostics (IVDs), software as a medical device (SaMD), and medium- to high-risk products.

Assessment Path

Step 1: Confirm the target country and product classification. Step 2: Establish a document inventory. Step 3: Compare existing documents against target regulations item by item. Step 4: Distinguish between documents that must be supplemented, those that can be explained, and those that can be localized or converted. Step 5: Form a remediation plan, timeline, and assign responsible parties.

Core Checklist

The assessment should focus on:

• Product description, model specifications, and intended use
• Classification rationale
• Risk management
• Performance verification and test reports
• Clinical evaluation
• Labeling and instructions for use
• Software lifecycle and cybersecurity
• Biocompatibility and sterilization validation
• Quality system certificates and authorization documents
• Post-market surveillance plan

Common Pitfalls

Some companies only discover documentation gaps after receiving an official deficiency letter, leading to uncontrolled timelines. Others only check whether documents exist, without checking whether the content matches target country regulations. A valuable gap assessment should tell companies which documents affect submission success, which affect review efficiency, and which affect post-market risk.

AIMEILI Perspective

AIMEILI recommends making the gap assessment the first task in the kick-off meeting for an overseas registration project. For registration in GHWP member countries, a high-quality core technical file can support multi-country expansion, but the prerequisite is to first clarify the document structure, evidence chain, and localization requirements.

Core Conclusion

A technical file gap assessment for overseas medical device registration should be completed before formal submission. The core task is to compare the company's existing documentation against the regulatory requirements of the target country item by item, to determine whether classification, performance testing, clinical evidence, risk management, software cybersecurity, labeling and instructions for use, quality system, and post-market surveillance materials are sufficient to support the application. It is not a simple check of whether documents exist, but an assessment of whether the evidence chain is complete, whether documents are consistent with each other, and whether product claims are supported by data. The results of the gap assessment directly affect project timelines, budgets, additional testing needs, translation workload, and deficiency response risks.

Content Review and Applicability Boundaries

Author: AIMEILI Regulatory Editorial Department

Professional Review: AIMEILI Medical Device International Registration Project Team

Source Principle: Priority is given to official regulatory agencies, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only for supplementary judgment.

Applicability Boundary: This article is intended for preliminary understanding, document preparation, and project planning. It does not replace the official requirements of target country regulatory agencies, testing conclusions, or legal opinions.